SPHAERO
→
Domaines
Revues
Institutions
Collections
À propos
Nos services
Connexion
S'inscrire
FR
EN
→
Domaines
Revues
Institutions
Collections
À propos
Nos services
Connexion
S'inscrire
KR
Koert Ritmeijer
Publications (8)
A randomized trial of AmBisome monotherapy and AmBisome and miltefosine combination to treat visceral leishmaniasis in HIV co-infected patients in Ethiopia
Article scientifique · 2019
Effectiveness of combination therapy with liposomal amphotericin B and miltefosine for visceral leishmaniasis in HIV coinfection: DNDi/MSF strategy for policy change in East Africa
Article scientifique · 2018
Failure of an innovative low-cost, non-invasive thermotherapy device in treating cutaneous leishmaniasis in Pakistan
Article scientifique · 2018
Leishmania Antigenuria to Predict Initial Treatment Failure and Relapse in Visceral Leishmaniasis/HIV Coinfected Patients: An Exploratory Study Nested Within a Clinical Trial in Ethiopia
Article scientifique · 2018
A clinical severity scoring system for visceral leishmaniasis in immunocompetent patients in South Sudan
Article scientifique · 2017
Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in an area of Ethiopia with a high burden of HIV co-infection
Article scientifique · 2017
Development and external validation of a clinical prognostic score for death in visceral leishmaniasis patients in a high HIV co-infection burden area in Ethiopia
Article scientifique · 2017
A Comparison of the Effectiveness of Sodium Stibogluconate Monotherapy to Sodium Stibogluconate and Paromomycin Combination for the Treatment of Severe Post Kala Azar Dermal Leishmaniasis in South Sudan – A Retrospective Cohort Study
Article scientifique · 2016
Domaines principaux
Sciences de la santé
5
Statistiques
Consultations
11
Téléchargements
0
Votre avis compte
Une suggestion, un bug, un ressenti sur SPHAERO ? Une minute suffit.
Plus tard
Donner mon avis
Votre avis compte
Nom
(optionnel)
Courriel
(optionnel)
Type de retour
Suggestion
Avis général
Signaler un bug
Message
Annuler
Envoyer
Merci, votre message a bien été envoyé.